Literature DB >> 11905758

Very rare cancers--a problem neglected.

.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11905758     DOI： 10.1016/s1470-2045(00)00273-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  The occurrence of rare cancers in U.S. adults, 1995-2004.

Authors:  Robert T Greenlee; Marc T Goodman; Charles F Lynch; Charles E Platz; Lori A Havener; Holly L Howe
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

2.  The End-of-Life Experience of Patients With Rare Cancers and Their Caregivers.

Authors:  Elizabeth Trice Loggers; Holly G Prigerson
Journal:  Rare Tumors       Date:  2014-03-24

Review 3.  Rare cancers: Challenges & issues.

Authors:  Raveendran K Pillai; K Jayasree
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

4.  Communication strategies for rare cancers: a systematic review protocol.

Authors:  Catherine Bell; Katie Kerr; Kerry Moore; Charlene McShane; Lesley Anderson; Amy Jayne McKnight; Helen McAneney
Journal:  Syst Rev       Date:  2019-04-23

5.  First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.

Authors:  Johannes Eberhard; Daniela Hirsch; Oliver Schilling; Wilhelm G Dirks; Feng Guo; Alice Fabarius; Felix Rückert; Christoph Reißfelder; Peter Hohenberger; Prama Pallavi
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

6.  Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey.

Authors:  Eline de Heus; Vivian Engelen; Irene Dingemans; Carol Richel; Marga Schrieks; Jan Maarten van der Zwan; Marc G Besselink; Mark I van Berge Henegouwen; Carla M L van Herpen; Saskia F A Duijts
Journal:  Orphanet J Rare Dis       Date:  2021-06-01       Impact factor: 4.123

7.  Vulvar Cancer: Facing a Rare Disease.

Authors:  Mario Preti; Denis Querleu
Journal:  Cancers (Basel)       Date:  2022-03-20       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.